FOXP3 and synovial sarcoma: However, it has been a matter of controversy whether or not malignant cells express FOXP3 and display a Treg phenotype in vivo, and very different frequencies of FOXP3-positive malignant cells have been reported in different cohorts of SS patients24–29.